Patents by Inventor Bong Kiun Kaang

Bong Kiun Kaang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intercellular proximity labeling using eGRASP
    Patent number: 11879895
    Abstract: The present disclosure relates to an intercellular proximity labeling technique. According to an embodiment of the present disclosure, intercellular proximities can be distinguished by cell types, in particular, synapses of nerve cells can be distinguished by types.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: January 23, 2024
    Assignee: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
    Inventors: Bong-Kiun Kaang, Jun Hyeok Choi, Ji-il Kim, Dong Ii Choi, Su-Eon Sim
  • INTERCELLULAR PROXIMITY LABELING USING EGRASP
    Publication number: 20210164986
    Abstract: The present disclosure relates to an intercellular proximity labeling technique. According to an embodiment of the present disclosure, intercellular proximities can be distinguished by cell types, in particular, synapses of nerve cells can be distinguished by types.
    Type: Application
    Filed: April 25, 2019
    Publication date: June 3, 2021
    Inventors: Bong-Kiun KAANG, Jun Hyeok CHOI, Ji-il KIM, Dong II CHOI, Su-Eon SIM
  • DEVICE FOR WIRELESSLY STIMULATING BODY USING LIGHT
    Publication number: 20160175611
    Abstract: A device for stimulating a body using light is disclosed. The device for stimulating a body using light includes a transmission light generator capable of generating light; and a body organ stimulator that generates stimulating light for stimulating a body organ when transmission light received from the transmission light generator includes light of a preset wavelength band.
    Type: Application
    Filed: December 22, 2015
    Publication date: June 23, 2016
    Applicant: RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
    Inventors: Tae-Il Kim, Bong-Kiun Kaang, Byeong-Hak Park, Woo-Jin Jung
  • Genetically engineered mouse model for autism spectrum disorder having deletion of gene and use thereof
    Patent number: 9232775
    Abstract: The present disclosure relates to an ASD genetically engineered model carrying a deletion of Shank2 gene and having reduced NMDA receptor function. According to the present disclosure, genetically engineered mice that show the clinical features of ASD due to the deletion of the Shank2 gene can be obtained, and the genetically engineered mice can be effectively used to screen candidate therapeutic agents.
    Type: Grant
    Filed: August 2, 2013
    Date of Patent: January 12, 2016
    Assignees: Industry-Academic Cooperation Foundation, Yonsei University, Seoul National University R&DB Foundation, Korea Advanced Institute of Science and Technology
    Inventors: Min Goo Lee, Bong Kiun Kaang, Eunjoon Kim
  • GENETICALLY ENGINEERED MOUSE MODEL FOR AUTISM SPECTRUM DISORDER HAVING DELETION OF SHANK2 GENE AND USE THEREOF
    Publication number: 20140041062
    Abstract: The present disclosure relates to an ASD genetically engineered model carrying a deletion of Shank2 gene and having reduced NMDA receptor function. According to the present disclosure, genetically engineered mice that show the clinical features of ASD due to the deletion of the Shank2 gene can be obtained, and the genetically engineered mice can be effectively used to screen candidate therapeutic agents.
    Type: Application
    Filed: August 2, 2013
    Publication date: February 6, 2014
    Applicants: Industry-Academic Cooperation Foundation, Yonsei University, Korea Advanced Institute of Science and Technology, Seoul National University R&DB Foundation
    Inventors: Min Goo Lee, Bong Kiun Kaang, Eunjoon Kim